Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
Clinical trial NCT02621398 · COMPLETED
Trial details
- NCT number
- NCT02621398
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-04
- Primary completion
- 2019-10-24
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.